Moneycontrol PRO
Open App
you are here: HomeNewsBusiness

COVID-19 impact | Ola to lay off 1,400 employees as revenue dips 95% in two months

In an email to employees, CEO Bhavish Aggarwal assured that this is a one-time exercise and no more COVID-19 related cuts will be done after this

May 20, 2020 / 07:17 PM IST

Cab aggregator Ola will lay off about 1,400 of its employees from the rides, financial services and food businesses as revenues declined by 95 percent in the last two months due to coronavirus outbreak.

This 1,400 translates to roughly 25 percent of the company's workforce.

In an email to employees, CEO Bhavish Aggarwal said: "..I write to all of you with the toughest decision I have ever taken – the need to downsize our organization and let go of 1,400 of our valued employees."

He made it clear that the prognosis ahead for the business is "very unclear and uncertain" and the impact of this crisis is "definitely going to be long-drawn for us".

However, he also assured that this will be a one-time exercise and no more COVID-related cuts will be done after this.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"The fallout of the virus has been very tough for our industry in particular. Our revenue has come down 95 per cent over the past 2 months. Most importantly, this crisis has affected the livelihoods of millions of our drivers and their families across India and our international geographies," he said.

Read the full text of Bhavish Aggarwal's letter to employees
Moneycontrol News
first published: May 20, 2020 01:37 pm
ISO 27001 - BSI Assurance Mark